Cellular mechanisms underlying the long QT syndrome

Current Opinion in Cardiology

Volumn 17, Issue 1, 2002, Pages 43-51

  Antzelevitch, Charles ^a   Shimizu, Wataru ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ELECTROCARDIOGRAPHY; HEART MUSCLE; HUMAN; LONG QT SYNDROME; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PURKINJE FIBER; REPOLARIZATION; REVIEW; T WAVE; TORSADE DES POINTES;

ANIMALS; ELECTROCARDIOGRAPHY; HUMANS; ION CHANNELS; LONG QT SYNDROME; TORSADES DE POINTES;

EID: 0036149136     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200201000-00007     Document Type: Review

References (96)

1. The idiopathic long QT syndrome: Progress and questions
2. The long QT syndrome: Prospective longitudinal study of 328 families
3. The long QT interval syndrome: A Rosetta stone for sympathetic related ventricular tachyarrhythmias
4. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
5. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
6. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
7. Mutations in the hminK gene cause long QT syndrome and suppress IKs function
8. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel
9. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia
10. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel
11. KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current
12. The QT interval
13. Electrophysiological remodeling in hypertrophy and heart failure
14. Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: Potential link between contractile adaptation and arrhythmogenesis
15. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes
16. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: Role of sustained inward current
17. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes
18. Electrical heterogeneity, the ECG, and cardiac arrhythmias
19. The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart
20. The controversial M cell
21. Electrical heterogeneity in the heart: Physiological, pharmacological and clinical implications
22. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle: The M cell
23. Heterogeneity within the ventricular wall: Electrophysiology and pharmacology of epicardial, endocardial and M cells
24. Regional differences in electrophysiologic properties of epicardium, midmyocardium and endocardium: In vitro and in vivo correlations
25. Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial and endocardial myocytes: A weaker IKs contributes to the longer action potential of the M cell
26. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle
27. INa-Ca contributes to electrical heterogeneity within the canine ventricle
28. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: The role of M cells in the generation of U waves, triggered activity and torsade de pointes
29. M cells and transmural heterogeneity of action potential configuration in myocytes from the left ventricular wall of the pig heart
30. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle
31. Drug-induced afterdepolarizations and triggered activity occur in a discrete subpopulation of ventricular muscle cell (M cells) in the canine heart: Quinidine and digitalis
32. Distribution of M cells in the canine ventricle
33. Electrophysiologic characteristics of M cells in the canine left ventricular free wall
34. Electrophysiological characteristics of cells spanning the left ventricular wall of human heart: Evidence for the presence of M cells
35. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo. Torsades de pointes develops with halothane but not pentobarbital anesthesia
36. Evidence for the presence of M cells in the guinea pig ventricle
37. Transmural heterogeneity of action potentials and Ito 1 in myocytes isolated from the human right ventricle
38. Lack of evidence of M-cells in porcine left ventricular myocardium
39. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing Torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome
40. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome: Tridimensional mapping of activation and recovery patterns
41. +-channel blocking agents on subendocardium and mid-wall slices of human, rabbit, and guinea pig myocardium
42. Acceleration-induced action potential prolongation and early afterdepolarizations
43. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsade de pointes in models of acquired and congenital long QT syndromes
44. Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome: Effects of β-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes
45. Cellular and ionic basis for T wave alternans under long QT conditions
46. Characteristics and distribution of M cells in arterially-perfused canine left ventricular wedge preparations
47. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome
48. Comparison of the cellular electrophysiological characteristics of canine left ventricular epicardium, M cells, endocardium and Purkinje fibres
49. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart
50. Ionic mechanisms underlying the effects of sodium pentobarbital to diminish transmural dispersion of repolarization
51. Suppression of time-dependent outward current in guinea-pig ventricular myocytes: Actions of quinidine and amiodarone
52. Clinical implications of electrical heterogeneity in the heart: The electrophysiology and pharmacology of epicardial, M and endocardial cells
53. Regional differences in the electrophysiology of ventricular cells: Physiological and clinical implications
54. The role of M cells in acquired long QT syndrome, U waves and torsade de pointes
55. The contribution of K+ currents to electrical heterogeneity across the canine ventricular wall under normal and ischemic conditions
56. Cellular and ionic mechanisms underlying erythromycin-induced long QT and torsade de pointes
57. Preeminence of the left stellate ganglion in the long Q-T syndrome
58. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias
59. Differential response to β-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome
60. Transmural dispersion of repolarization and the T wave
61. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome
62. Multiple mechanisms of Na+ channel-linked long-QT syndrome
63. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome
64. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes
65. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-qt syndrome: Direct evidence from intracellular recordings in the intact left ventricular wall
66. Polymorphic ventricular tachycardia and torsades de pointes: Beyond etymology
67. Mechanisms for spontaneous changes in QRS morphology sometimes resembling torsades de pointes during reentrant ventricular tachycardia in a canine infarct model
68. Experimental models of torsade de pointes
69. Polymorphic ventricular tachycardias induced by d-sotalol and phenylephrine in canine preparations of atrioventricular block: Initiation in the conduction system followed by spatially unstable re-entry
70. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome
71. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome
72. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: Detailed analysis of ventricular tri-dimensional activation patterns
73. Optical maps reveal reentrant mechanism of torsade de pointes based on topography and electrophysiology of mid-myocardial cells
74. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart
75. The mechanism of simulated torsades de pointes in computer model of propagated excitation
76. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle
77. A new look at torsades de pointes
78. Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations?
79. Early afterdepolarizations and triggered activity in clinical arrhythmias
80. Long QT syndrome
81. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings
82. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase
83. TU alternans, long QTU, and torsade de pointes: Clinical and experimental observations
84. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block
85. Long QT syndrome patients with mutations of the SCN5A and HEIRG genes have differential responses to Na+ channel blockade and to increases in heart rate: Implications for gene-specific therapy
86. The long QT syndrome
87. Genetically defined therapy of inherited long-QT syndrome: Correction of abnormal repolarization by potassium
88. Normalization of acquired QT prolongation in humans by intravenous potassium
89. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long QT syndrome
90. Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome
91. Mode of onset of torsade de pointes in congenital long QT syndrome
92. Correlation of genetic etiology with response to beta-adrenergic blockade among symptomatic patients with familial long-QT syndrome
93. Effects of flecainide in patients with new SCN5A mutation: Mutation- specific therapy for long-QT syndrome?
94. Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome
95. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome
96. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1)